James M. Hewitt

Array ( [id] => 5205715 [patent_doc_number] => 20070027197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers' [patent_app_type] => utility [patent_app_number] => 11/497130 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7515 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027197.pdf [firstpage_image] =>[orig_patent_app_number] => 11497130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253933 [patent_doc_number] => 20070135389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Tumor eradication by inositol-tripyrophosphate' [patent_app_type] => utility [patent_app_number] => 11/497566 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12472 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135389.pdf [firstpage_image] =>[orig_patent_app_number] => 11497566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5626005 [patent_doc_number] => 20060264510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Antiviral methods and compositions' [patent_app_type] => utility [patent_app_number] => 11/495903 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4295 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264510.pdf [firstpage_image] =>[orig_patent_app_number] => 11495903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530408 [patent_doc_number] => 20100015249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Antitumor agent containing 6\'-amidino-2\'-naphthyl 4-guanidinobenzoate or salt thereof' [patent_app_type] => utility [patent_app_number] => 11/989601 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10131 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015249.pdf [firstpage_image] =>[orig_patent_app_number] => 11989601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304192 [patent_doc_number] => 20090298844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'ABL KINASE INHIBITION' [patent_app_type] => utility [patent_app_number] => 11/989300 [patent_app_country] => US [patent_app_date] => 2006-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8555 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298844.pdf [firstpage_image] =>[orig_patent_app_number] => 11989300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5517086 [patent_doc_number] => 20090217393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Growth Promoting Agent and Life Prolonging Agent' [patent_app_type] => utility [patent_app_number] => 11/988352 [patent_app_country] => US [patent_app_date] => 2006-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6356 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20090217393.pdf [firstpage_image] =>[orig_patent_app_number] => 11988352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515596 [patent_doc_number] => 20090215903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Injectable Liquid Paracetamol Formulation' [patent_app_type] => utility [patent_app_number] => 12/084541 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3546 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215903.pdf [firstpage_image] =>[orig_patent_app_number] => 12084541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924173 [patent_doc_number] => 20060241089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Dipyridamole, acetylsalicylic acid, and angiotensin II antagonist pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/478184 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1934 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241089.pdf [firstpage_image] =>[orig_patent_app_number] => 11478184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606164 [patent_doc_number] => 20100063150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Aflatoxin Production Inhibitor and Method for Controlling Aflatoxin Contamination Using the Same' [patent_app_type] => utility [patent_app_number] => 11/922703 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12013 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063150.pdf [firstpage_image] =>[orig_patent_app_number] => 11922703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994248 [patent_doc_number] => 20070009593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Methods of treating cancer' [patent_app_type] => utility [patent_app_number] => 11/451875 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12971 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009593.pdf [firstpage_image] =>[orig_patent_app_number] => 11451875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859999 [patent_doc_number] => 20060229345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Compositions comprising epothilones and their use for the treatment of carcinoid syndrome' [patent_app_type] => utility [patent_app_number] => 11/451286 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4286 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229345.pdf [firstpage_image] =>[orig_patent_app_number] => 11451286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624919 [patent_doc_number] => 20060263424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Pharmaceutical compositions comprising clavulanic acid' [patent_app_type] => utility [patent_app_number] => 11/449041 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6304 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263424.pdf [firstpage_image] =>[orig_patent_app_number] => 11449041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754662 [patent_doc_number] => 20060223811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Triglycerine depressant composition' [patent_app_type] => utility [patent_app_number] => 11/447735 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3411 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223811.pdf [firstpage_image] =>[orig_patent_app_number] => 11447735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890244 [patent_doc_number] => 20060276548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'INHIBITORS OF ENDO-EXONUCLEASE ACTIVITY FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 11/420358 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7978 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276548.pdf [firstpage_image] =>[orig_patent_app_number] => 11420358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786870 [patent_doc_number] => 20060205806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Synergistic combination' [patent_app_type] => utility [patent_app_number] => 11/433419 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2600 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205806.pdf [firstpage_image] =>[orig_patent_app_number] => 11433419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247840 [patent_doc_number] => 20070244074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Stable parenteral formulation of fosphenytoin sodium' [patent_app_type] => utility [patent_app_number] => 11/405197 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2142 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244074.pdf [firstpage_image] =>[orig_patent_app_number] => 11405197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368641 [patent_doc_number] => 20090306200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Prophylactic or Therapeutic Agent for Nocturnal Conduct Disorder Associated With Dementia' [patent_app_type] => utility [patent_app_number] => 11/887753 [patent_app_country] => US [patent_app_date] => 2006-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3305 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306200.pdf [firstpage_image] =>[orig_patent_app_number] => 11887753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699661 [patent_doc_number] => 20060216345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Oral pharmaceutical composition including paroxetine' [patent_app_type] => utility [patent_app_number] => 11/388725 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2860 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216345.pdf [firstpage_image] =>[orig_patent_app_number] => 11388725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733637 [patent_doc_number] => 20060258754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Method of treating endothelial dysfunction, oxidative stress and related diseases' [patent_app_type] => utility [patent_app_number] => 11/386150 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258754.pdf [firstpage_image] =>[orig_patent_app_number] => 11386150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656655 [patent_doc_number] => 20060142391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'PPARGAMMA-ACTIVATING PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 11/277123 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4816 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142391.pdf [firstpage_image] =>[orig_patent_app_number] => 11277123 [rel_patent_id] =>[rel_patent_doc_number] =>)